★Viatris is a Fortune 254 ranked Global Healthcare company formed in Nov. 2020 through the combination of Mylan & Upjohn (Pfizer). Viatris has a global workforce of 40,000 and portfolio includes best-in-class, iconic brand name products as well as global key brands; generics, including branded and complex generics; biosimilars; and over-the-counter offerings across a wide range of therapeutic areas. I am placed at Bangalore Corporate Office of Complex Injectable Manufacturing Division and we are having five manufacturing units, with all facilities approved by Global Regulatory Authority (USFDA).

★Reporting to Sr VP Eng. & Projects, Global Injectable Manufacturing I was hired with the objective of bringing my extensive project experience to bear on reviewing and improving Project Governance framework effectiveness in addition to building several new facilities, including, but not limited to, the following:
+Benchmarking global project management standard, driven by planned approach,
+Analysis and implementation of CQV and project variance analysis,
+Introduce Science & risk-based approach for project, process, product and plant,
+Introduce critical aspects of manufacturing systems and follow GMP, based on product & process understanding,
+Improved method of manufacturing with advanced equipment & technologies in place.

★Key Accomplishments:

C&Q Lead, Large Complex Sterile Injectable Formulation project in India, 2015-2017
►Successfully delivered complex sterile injectable formulation project in Bangalore India.
►Impact: The facility was built to manufacture end products like microspheres, nano suspensions, regular suspensions, liposomes, emulsions & gels and USFDA standard.

PMO, Sterile Injectable Finished Formulation Oncology Facility in India. 2017-2020.
►Successfully delivered brownfield Sterile Onco Injectable facility
►Impact: Substantial cost saving.

Project Head, Technology Transfer Project for Indonesia,2019-2022 (ongoing)